📢 New paper just out in npj Journals #PrecisionOncology! We developed a #BreastCancer Purity Score (#BCPS) able to improve #prognostication and #omics data interpretation by quantifying the #tumour content in #clinical samples. Well done Marco Barreca! nature.com/articles/s4169…

📣 Also online today! A fantastic collection of ER+ #breastcancer #PDX to study #heterogeneity and #resistance by Barbara Belletti Gustavo Baldassarre at Centro di Riferimento Oncologico! Happy to have contributed to unveil the molecular changes induced by CDK4/6 inhibition. …thsocjournals.onlinelibrary.wiley.com/doi/10.1002/pa…

Successful Virtual Mobility Grant of Marco Barreca from Unviersity of Milano on Omics Data Gathering ⚗ 💻 Developed computational tools will enable researchers to access and organize relevant data, contributing to translational research. #immunomodel #immunotherapy #COST

Researchers from Fondazione Michelangelo and Milan-Bicocca University developed and validated a 9-gene Breast Cancer Purity Score able to estimate tumour content in patient-derived samples fondazionemichelangelo.org/2024/11/04/a-n… Marco Barreca Giampaolo Bianchini Maurizio Callari @dugo_matteo Università degli Studi di Milano-Bicocca

📢Our work just published in Nature Communications Nature Portfolio! What is driving #response to #targeted #treatments in HER2+ER+ #breastcancer? How is the tumour ecosystem affected by treatment? Find the answers in our paper 👉 rdcu.be/ecbVR Key points below 👇

Here an overview of our #translational research on samples from #NAPHER2 trial recently published in Nature Communications. We identified #predictive #biomarkers and molecular dynamics in HER2+ER+ #breastcancer receiving chemo-free #targeted #treatment 👇

Super happy to see this out! 😊 A nice piece of work I contributed to during my time in Cambridge. It highlights the potential of liquid biopsy paired with advanced statistical modelling! Well done Oscar M Rueda Solon Karapanagiotis and co!!

📌 Third IMMUNO-model Annual Conference “Modeling Immunotherapy for Cancer: Bridging Research to Clinical Application” has officially started! 👨‍🔬 👩‍🔬 Amazing talks at IMMUNO-model COST conference and welcome session of the chair! #immunomodel #COST #immunotherapy

🧬 We are reflecting the day 1 IMMUNO-model conference and the scientific program featuring sessions dedicated to in vitro and in vivo models, reflecting the full breadth of approaches used to understand and develop immunotherapies. #COST #immunomodel #imunotherapy #patients

My thanks to #IMMUNOmodel COSTAction for the opportunity to speak at the 3rd Annual Meeting in Warsaw, Poland on the challenges facing pre-clinical researchers working on modelling immunotherapies! DCU Research DCU Science and Health DCU Life Sciences Institute DCU School of Biotechnology immunomodel